- $482.41m
- $468.67m
- $558.27m
- 97
- 73
- 94
- 99
Annual cashflow statement for IBEX, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2021 June 30th | C2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.1 | 21.5 | 31.6 | 33.7 | 36.9 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.8 | 16.9 | 20.5 | 19.7 | 20.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27 | -11.3 | -33.7 | -37.3 | -26.3 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 16.1 | 40 | 41.9 | 35.9 | 45.7 |
| Capital Expenditures | -20.8 | -25.9 | -19 | -8.86 | -18.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | -0.085 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Cash from Investing Activities | -20.8 | -25.9 | -19 | -8.86 | -18.4 |
| Financing Cash Flow Items | -8.09 | -0.818 | -0.447 | -0.49 | -0.953 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 40.9 | -22.1 | -13.6 | -21.7 | -74.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36 | -9.01 | 8.6 | 5.29 | -47.4 |